WASHINGTON: COVID-19 vaccinations for children under 5 hit another monthslong delay Friday as US regulators abruptly put the brakes on their efforts to speed review of the shots that Pfizer is testing for youngsters.
The US Food and Drug Administration, worried about the omicron variant’s toll on kids, had taken the extraordinary step of urging Pfizer to apply for OK of the extra-low dose vaccine before it’s clear if tots will need two shots or three. The agency’s plan could have allowed vaccinations to begin within weeks.